Abstract: Disclosed are compositions and methods for treating or ameliorating the symptoms of cancer (e.g., oral cancer) by using a poly-pharmaceutical drug, whose composition consists of relationally optimized ratios of bioactive compounds to enhance their pharmacological characteristics.

Abstract: Disclosed are compositions and methods for treating or ameliorating the symptoms of cancer (e.g., oral cancer) by using a poly-pharmaceutical drug, whose composition consists of relationally optimized ratios of bioactive compounds to enhance their pharmacological characteristics.

Abstract: Disclosed are compositions and methods for treating or ameliorating the symptoms of cancer (e.g., oral cancer) by using a poly-pharmaceutical drug, whose composition consists of relationally optimized ratios of bioactive compounds to enhance their pharmacological characteristics.

Abstract: The present invention relates to a novel synergic herbal formulation comprising Curcuma longa and Phylanthus emblica in precise combination along with one or more other ingredient for prevention and treatment of pre-diabetes, diabetes mellitus and other insulin resistance cases. Further the present invention provides a process for preparing the novel synergistic herbal formulation.

Abstract: The present invention provides compositions and formulations of biologically active compounds complexed with a solid lipid particle which is able to traverse the blood-retinal barrier and treat retinal and neurological diseases.

Abstract: The present invention provides a delivery system which improves the stability, solubility and permeability of certain types of biologically active compounds in the gut after oral consumption. The delivery system comprises carrier granule comprising an agglomeration of solid lipid particles and a biologically active compound. The biologically active compound may be used with the delivery system to treat illnesses relating to inflammation, oxidation, or protein aggregation where a therapeutic blood and tissue level is required for treating the illness.

Abstract: The present invention provides a delivery system which improves the stability, solubility and permeability of certain types of biologically active compounds in the gut after oral consumption. The delivery system comprises carrier granule comprising an agglomeration of solid lipid particles and a biologically active compound. The biologically active compound may be used with the delivery system to treat illnesses relating to inflammation, oxidation, or protein aggregation where a therapeutic blood and tissue level is required for treating the illness.

Abstract: The present invention relates to a composition for use in a nutritional product, dietary supplement, food or pharmaceutical composition wherein such composition includes the plant Tinospora cordifolia or Tinospora cordifolia extract and is used to treat allergies, including but not limited to seasonal, perennial, or sporadic allergic rhinitis. The present invention further relates to an extraction process for obtaining such composition.

Abstract: The present invention relates to a composition containing Cissus quadrangularis from the family Cissus sp. or its extracts for use in a nutritional product, dietary supplement or pharmaceutical composition wherein the composition provides prevention and treatment of osteo-health related disorders and diseases as well as effective fracture healing through the use of anabolic steroid properties that increase the therapeutic process. The invention also relates to an extraction process for obtaining such composition.